---
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/272304053.md"
description: "Pfizer plans to strengthen the application of AI across all its businesses"
datetime: "2026-01-12T17:51:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272304053.md)
  - [en](https://longbridge.com/en/news/272304053.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272304053.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/272304053.md) | [English](https://longbridge.com/en/news/272304053.md)


# 

Pfizer plans to strengthen the application of AI across all its businesses

### 相關股票

- [Pfizer (PFE.US)](https://longbridge.com/zh-HK/quote/PFE.US.md)

## 相關資訊與研究

- [Pfizer Gains Chinese Approval for GLP-1 Weight Management Drug Enochlutide](https://longbridge.com/zh-HK/news/278064724.md)
- [Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis | PFE Stock News](https://longbridge.com/zh-HK/news/278375686.md)
- [Eridu AI announced that it has received $200 million in funding from a group of investors](https://longbridge.com/zh-HK/news/278585527.md)
- [This 1 Little-Known AI Stock Is up 50% Already in 2026. Should You Buy It Now?](https://longbridge.com/zh-HK/news/278131143.md)
- [CData targets development success with Connect AI update](https://longbridge.com/zh-HK/news/278394807.md)